|
Volumn 1, Issue 1, 2001, Pages 31-41
|
DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibition.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA;
ENZYME INHIBITOR;
LIGAND;
TELOMERASE;
CELL LINE;
CELL SURVIVAL;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
HUMAN;
REVIEW;
STRUCTURE ACTIVITY RELATION;
ANTINEOPLASTIC AGENTS;
CELL LINE;
CELL SURVIVAL;
DNA;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
LIGANDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
TELOMERASE;
|
EID: 0035352382
PISSN: 13895575
EISSN: None
Source Type: Journal
DOI: 10.2174/1389557013407304 Document Type: Review |
Times cited : (45)
|
References (82)
|